Your browser version may not work well with NCBI's Web applications. More information here...
1: Am J Obstet Gynecol. 1998 Feb;178(2):397-401.Links

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep.

Department of Reproductive Biology and Obstetrics and Gynecology, Case Western University and MetroHealth Medical Center, Cleveland, Ohio 44106, USA.

OBJECTIVE: Our purpose was to assess the effects of an intravenous dose of a highly selective mu-(DALDA) and delta-(DPDPE) opioid peptide to determine which class of peptide has the best clinical potential. STUDY DESIGN: Chronically instrumented pregnant ewes received a 0.3 mg/kg intravenous bolus of each peptide with and without opioid receptor blockade by means of a randomized prospective design. RESULTS: Intravenous DALDA produced only mild hypertension and a loss of heart rate variability, whereas DPDPE produced respiratory depression, maternal hypertension, and a fall in heart rate in both mother and fetus. Uterine blood flow, oxygen uptake, and glucose uptake were unchanged with both drugs. The effects of DALDA but not DPDPE were reversed by opioid receptor blockade. CONCLUSION: The delta-selective agonist had multiple nonopioid adverse effects, whereas the mu-selective agonist was well tolerated by the pregnant ewe, suggesting that mu-selective agonists have better potential for clinical use as an analgesic in pregnancy.

PMID: 9500506 [PubMed - indexed for MEDLINE]